Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-046015
Filing Date
2024-11-07
Accepted
2024-11-07 08:48:55
Documents
65
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vcel-20240930.htm   iXBRL 10-Q 1109171
2 EX-10.1 ex101eleventhamendmenttoth.htm EX-10.1 34518
3 EX-31.1 ex311ceocertificationq32024.htm EX-31.1 13489
4 EX-31.2 ex312cfocertificationq32024.htm EX-31.2 11566
5 EX-32.1 ex321ceoandcfosoxcertifica.htm EX-32.1 9390
  Complete submission text file 0001628280-24-046015.txt   5875630

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcel-20240930.xsd EX-101.SCH 32583
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vcel-20240930_cal.xml EX-101.CAL 63692
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vcel-20240930_def.xml EX-101.DEF 152933
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcel-20240930_lab.xml EX-101.LAB 523750
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcel-20240930_pre.xml EX-101.PRE 340197
67 EXTRACTED XBRL INSTANCE DOCUMENT vcel-20240930_htm.xml XML 844564
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35280 | Film No.: 241433407
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)